Dr Dale Garsed
Honorary Conjoint Senior Fellow
The Sir Peter MacCallum Department of Oncology
90 Scholarly works
9 Projects
HIGHLIGHTS
2026
Journal article
IdentifiHR predicts homologous recombination deficiency in high-grade serous ovarian carcinoma using gene expression
DOI: 10.1038/s43856-026-01387-y2026
Journal article
Clinicopathologic and molecular predictors of survival in BRCA-deficient tubo-ovarian high-grade serous carcinoma.
DOI: 10.1038/s41467-026-71134-32024
Research grants (ARC, NHMRC, MRFF)
Harnessing the Immune Response in Exceptionally Long-Term Survivors of Ovarian Cancer to Develop Novel Therapeutics
2023
Research grants (other domestic)
Learning From Survivors: Profiling Patients With Extraordinary Response and Survival to Improve Outcomes for Women With Ovarian Cancer
2020
Research Grant
Understanding Adverse and Exceptional Outcomes in Ovarian Cancer
2015
Journal article
Whole-genome characterization of chemoresistant ovarian cancer
DOI: 10.1038/nature144102014
Journal article
The Architecture and Evolution of Cancer Neochromosomes
DOI: 10.1016/j.ccell.2014.09.010
RECENT SCHOLARLY WORKS
2026
Journal article
Real-world comparative outcomes of neoadjuvant chemotherapy with interval cytoreductive surgery versus primary cytoreductive surgery in epithelial ovarian cancer: insights from the australian ovarian cancer study (AOCS)
DOI: 10.1016/j.ijgc.2025.1030762026
Other
Supplementary Figure S1 from Oxford Classic–Defined EMT Risk Stratification of High-Grade Serous Ovarian Cancer for Guiding Treatment Decisions
DOI: 10.1158/1078-0432.310068692026
Other
Supplementary Figure S2 from Oxford Classic–Defined EMT Risk Stratification of High-Grade Serous Ovarian Cancer for Guiding Treatment Decisions
DOI: 10.1158/1078-0432.310068662026
Other
Supplementary Figure S5 from Oxford Classic–Defined EMT Risk Stratification of High-Grade Serous Ovarian Cancer for Guiding Treatment Decisions
DOI: 10.1158/1078-0432.310068542026
Other
Supplementary Figure S4 from Oxford Classic–Defined EMT Risk Stratification of High-Grade Serous Ovarian Cancer for Guiding Treatment Decisions
DOI: 10.1158/1078-0432.310068572026
Other
Supplementary Figure S3 from Oxford Classic–Defined EMT Risk Stratification of High-Grade Serous Ovarian Cancer for Guiding Treatment Decisions
DOI: 10.1158/1078-0432.310068632026
Other
Data from Oxford Classic–Defined EMT Risk Stratification of High-Grade Serous Ovarian Cancer for Guiding Treatment Decisions
DOI: 10.1158/1078-0432.c.82320932026
Other
Supplementary Table S1 from Oxford Classic–Defined EMT Risk Stratification of High-Grade Serous Ovarian Cancer for Guiding Treatment Decisions
DOI: 10.1158/1078-0432.31006851